General Information of Drug Off-Target (DOT) (ID: OTP65YD7)

DOT Name RAB6-interacting golgin (GORAB)
Synonyms N-terminal kinase-like-binding protein 1; NTKL-BP1; NTKL-binding protein 1; hNTKL-BP1; SCY1-like 1-binding protein 1; SCYL1-BP1; SCYL1-binding protein 1
Gene Name GORAB
Related Disease
Diabetic retinopathy ( )
Geroderma osteodysplastica ( )
Non-insulin dependent diabetes ( )
Bone disease ( )
Hepatocellular carcinoma ( )
Neoplasm ( )
Osteoporosis ( )
Androgenetic alopecia ( )
Baldness, male pattern ( )
UniProt ID
GORAB_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF04949
Sequence
MAQGWAGFSEEELRRLKQTKDPFEPQRRLPAKKSRQQLQREKALVEQSQKLGLQDGSTSL
LPEQLLSAPKQRVNVQKPPFSSPTLPSHFTLTSPVGDGQPQGIESQPKELGLENSHDGHN
NVEILPPKPDCKLEKKKVELQEKSRWEVLQQEQRLMEEKNKRKKALLAKAIAERSKRTQA
ETMKLKRIQKELQALDDMVSADIGILRNRIDQASLDYSYARKRFDRAEAEYIAAKLDIQR
KTEIKEQLTEHLCTIIQQNELRKAKKLEELMQQLDVEADEETLELEVEVERLLHEQEVES
RRPVVRLERPFQPAEESVTLEFAKENRKCQEQAVSPKVDDQCGNSSSIPFLSPNCPNQEG
NDISAALAT
KEGG Pathway
p53 sig.ling pathway (hsa04115 )

Molecular Interaction Atlas (MIA) of This DOT

9 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Diabetic retinopathy DISHGUJM Definitive Biomarker [1]
Geroderma osteodysplastica DISFPJ78 Definitive Autosomal recessive [2]
Non-insulin dependent diabetes DISK1O5Z Definitive Biomarker [1]
Bone disease DISE1F82 Strong Genetic Variation [3]
Hepatocellular carcinoma DIS0J828 Strong Altered Expression [4]
Neoplasm DISZKGEW Strong Biomarker [4]
Osteoporosis DISF2JE0 Strong Genetic Variation [5]
Androgenetic alopecia DISSJR1P Limited Genetic Variation [6]
Baldness, male pattern DIS9C9RO Limited Genetic Variation [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of RAB6-interacting golgin (GORAB). [7]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of RAB6-interacting golgin (GORAB). [8]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of RAB6-interacting golgin (GORAB). [9]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of RAB6-interacting golgin (GORAB). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of RAB6-interacting golgin (GORAB). [11]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of RAB6-interacting golgin (GORAB). [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)

References

1 Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes.Diabetologia. 2015 Jun;58(6):1231-8. doi: 10.1007/s00125-015-3569-9. Epub 2015 Mar 28.
2 Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin. Nat Genet. 2008 Dec;40(12):1410-2. doi: 10.1038/ng.252. Epub 2008 Nov 9.
3 GORAB scaffolds COPI at the trans-Golgi for efficient enzyme recycling and correct protein glycosylation.Nat Commun. 2019 Jan 10;10(1):127. doi: 10.1038/s41467-018-08044-6.
4 SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma.Carcinogenesis. 2012 Aug;33(8):1581-8. doi: 10.1093/carcin/bgs162. Epub 2012 May 7.
5 Examining tissue composition, whole-bone morphology and mechanical behavior of Gorab(Prx1) mice tibiae: A mouse model of premature aging.J Biomech. 2017 Dec 8;65:145-153. doi: 10.1016/j.jbiomech.2017.10.018. Epub 2017 Oct 25.
6 GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.Nat Commun. 2017 Nov 17;8(1):1584. doi: 10.1038/s41467-017-01490-8.
7 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
8 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
9 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
10 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
11 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
12 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.